Cobuzzi Robert Joseph Jr. 4
4 · Diffusion Pharmaceuticals Inc. · Filed Mar 22, 2022
Insider Transaction Report
Form 4
Cobuzzi Robert Joseph Jr.
Chief Operating Officer
Transactions
- Purchase
Series C Convertible Preferred Stock
2022-03-18$0.50/sh+5,000$2,500→ 5,000 totalExercise: $0.50→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the "Shares"), from the Issuer at a purchase price of $0.50 per Share in a private placement. The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a "Reverse Stock Split") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a "mirrored" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares.